巴西人胰岛素公共筹资（2009-2017）

数据集获取（Figshare）

• 源站标题：Public financing of human insulins in Brazil: 2009-2017
• DOI：10.6084/m9.figshare.14321451.v1
• 发布日期：2021-03-26
• 文件数：4 个
• 文件总体积：22.53 KB
• 源站页面：https://scielo.figshare.com/articles/dataset/Public_financing_of_human_insulins_in_Brazil_2009-2017/14321451

命令行下载

curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/27274842"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/27274848"
curl -L -o "Table_3.xls" "https://ndownloader.figshare.com/files/27274851"
curl -L -o "Table_4.xls" "https://ndownloader.figshare.com/files/27274854"

文件清单

• Table_1.xls（5.63 KB）
• Table_2.xls（5.63 KB）
• Table_3.xls（5.63 KB）
• Table_4.xls（5.63 KB）

文件总体积 22.53 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

ABSTRACT: Background: From 2006 to 2017, the Brazilian federal government provided free of charge traditional insulins for diabetes treatment. This involved public tendering by the Department of Health Logistics of the Ministry of Health (DLOG-MOH) and the reimbursement after direct contracting for supply with commercial private retailers (Brazilian Popular Pharmacy Program - PFPB). Objective: We aim to describe the budget of the Brazilian federal government committed to for the acquisition of insulin, as well as corresponding prices and treatment availability from 2009 to 2017. Methods: Insulin volume and expenditure data were obtained in official administrative databases and in the Electronic System of the Information Service to Citizens. Data were analyzed according to the total provision by the federal government, DLOG-MOH and PFPB. Moreover, data were presented according to insulin type. Volumes were calculated in number of defined daily doses (DDD)/1,000 inhabitants/day. Results: Budgetary commitments due to insulin over nine years amounted to U$1,027 billion in 2017, with an approximate average of U$114.1 million per year. DLOG-MOH was the main insulin provider, despite the increase in PFPB provision along period. DLOG-MOH and PFBP together provided an average of 6.08 DDD/1000 inhabitants/day for nine years. Average prices in PFPB were higher than those in the DLOG series, with a downward trend over the years, narrowing to 2.7 times in 2017, when compared to 2009. Conclusions: Brazil evidenced a moderately sustainable and effective, albeit imperfect, policy for public provision of traditional insulins in the period preceding mandatory free supply of insulin analogues. Future studies must address treatment availability and financial sustainability in the new scenario.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.14321451.v1（source: https://scielo.figshare.com/articles/dataset/Public_financing_of_human_insulins_in_Brazil_2009-2017/14321451）。